Memscap (FRA:MSBA) YoY EBITDA Growth: -8.85% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MSBA Memscap SA FRA:MSBA
84 GF Score
Price €4.91
GF Value €4.77
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Memscap YoY EBITDA Growth?

Memscap FRA:MSBA -0.10% 84 YoY EBITDA Growth is -8.85% as of Dec. 2025. GuruFocus rates FRA:MSBA with a GF Score™ of 84/100 and a GF Value™ of €4.77 (Fairly Valued). The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Memscap's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was -8.85%.

Memscap's EBITDA per Share for the six months ended in Dec. 2025 was €0.10.

Memscap YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Memscap's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Memscap YoY EBITDA Growth Chart

Memscap Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.32 -11.01 103.61 -22.28 -21.50

Memscap Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.73 -8.49 -38.25 -28.87 -8.85
FRA:MSBA
84GF Score
Memscap SA FRA:MSBA
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Memscap YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Memscap's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.241-0.307)/ | 0.307 |
=-21.50 %

Memscap's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(0.103-0.113)/ | 0.113 |
=-8.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -8.85% mean?
Memscap (FRA:MSBA) has a YoY EBITDA Growth of -8.85% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Memscap and its competitors.
Is Memscap's YoY EBITDA Growth too high?
Memscap's current YoY EBITDA Growth is -8.85%. Overall, Memscap has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Memscap's YoY EBITDA Growth compare to AMAT and LRCX?
Memscap's YoY EBITDA Growth of -8.85% can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Semiconductors company?
A good YoY EBITDA Growth depends on the Semiconductors industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Memscap and its competitors. Memscap's current YoY EBITDA Growth is -8.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Memscap stock overvalued right now?
Based on GuruFocus' analysis, Memscap (FRA:MSBA) is currently considered Fairly Valued. The stock's GF Value™ is €4.77, compared to a current price of €4.91 — trading 2.9% above its estimated fair value. The current YoY EBITDA Growth is -8.85%. Memscap's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Memscap (FRA:MSBA), the current YoY EBITDA Growth is -8.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Memscap (FRA:MSBA) Overvalued in 2026?

Based on GuruFocus' analysis, Memscap stock appears to be overvalued. The current stock price of €4.91 is trading 2.9% above its estimated GF Value™ of €4.77. GuruFocus considers Memscap to be Fairly Valued.

Key valuation signals for FRA:MSBA:

  • YoY EBITDA Growth: -8.85%
  • GF Value™: €4.77 vs. price of €4.91 (2.9% above fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the FRA:MSBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Memscap Business Description

Other Exchanges 0NYT:UKMEMS:France
Address Parc Activillage des Fontaines, ZI Bernin, Bernin, FRA, 38190
Memscap SA is a France-based company. It is engaged in the provision of solutions based on micro-electromechanical systems (MEMS) technology. The company operates in four market segments: Aerospace, Medical / Biomedical, Mass Market / Other Applications, and Optical Communications / Adaptive Optics.
84GF Score

Get the complete analysis for FRA:MSBA

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.91
Price
€4.77
GF Value